BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis and biological evaluation of 7-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-2,3-dihydro-1H-inden-1-one derivatives as potent FAK inhibitors for the treatment of ovarian cancer. 2022

Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Laboratory of Emergency Medicine, Department of Emergency Medicine, Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, China.

Focal adhesion kinase (FAK) promotes tumor progression by intracellular signal transduction and regulation of gene expression and protein turnover, which is a compelling therapeutic target for various cancer types, including ovarian cancer. However, the clinical responses of FAK inhibitors remain unsatisfactory. Here, we describe the discovery of FAK inhibitors using a scaffold hopping strategy. Structure-activity relationship (SAR) exploration identified 36 as a potent FAK inhibitor, which exhibited inhibitory activities against FAK signaling in vitro. Treatment with 36 not only decreased migration and invasion of PA-1 cells, but also reduced expression of MMP-2 and MMP-9. Moreover, 36 inhibited tumor growth and metastasis, and no obvious adverse effects were observed during the in vivo study. These results revealed the potential of FAK inhibitor 36 for treatment of ovarian cancer.

UI MeSH Term Description Entries
D007189 Indans Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES. Indanones
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests

Related Publications

Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study.
September 2020, Bioorganic chemistry,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents.
December 2019, European journal of medicinal chemistry,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Design, Synthesis and Biological Evaluation of 4-Aryl-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one Derivatives as a PI3Kα Inhibitor.
January 2019, Biological & pharmaceutical bulletin,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Design, synthesis and anti-inflammatory evaluation of novel pyrrolo[2,3-d]pyrimidin derivatives as potent JAK inhibitors.
September 2019, Bioorganic & medicinal chemistry,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as selective Btk inhibitors with improved pharmacokinetic properties for the treatment of rheumatoid arthritis.
February 2018, European journal of medicinal chemistry,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Discovery of 4-(Piperazin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine Derivatives as Akt Inhibitors.
May 2016, Archiv der Pharmazie,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Design, synthesis and biological evaluation of 7H-pyrrolo[2,3-d]pyrimidine derivatives containing 1,8-naphthyridine-4-one fragment.
April 2021, European journal of medicinal chemistry,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
(E)-5,6-Dimeth-oxy-2-(pyridin-4-yl-methyl-idene)-2,3-dihydro-1H-inden-1-one.
October 2010, Acta crystallographica. Section E, Structure reports online,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors.
October 2012, Bioorganic & medicinal chemistry letters,
Wei Wei, and Zhanzhan Feng, and Zhihao Liu, and Xinyue Li, and Hualong He, and Kai Ran, and Yaojie Shi, and Yongxia Zhu, and Tinghong Ye, and Chao Gao, and Ningyu Wang, and Luoting Yu
Design, synthesis and evaluation of novel 7H-pyrrolo[2,3-d]pyrimidin-4-amine derivatives as potent, selective and reversible Bruton's tyrosine kinase (BTK) inhibitors for the treatment of rheumatoid arthritis.
May 2019, European journal of medicinal chemistry,
Copied contents to your clipboard!